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ABSTRACT
Cogan’s syndrome is a rare systemic inflammatory disease and can be diagnosed on the basis of typical inner ear and ocular 
involvement with the presence of large vessel vasculitis. We report a case of Cogan’s syndrome with stable angina resulting from 
coronary ostial stenosis caused by aortitis. (Korean Circ J 2010;40:680-683)
KEY WORDS: Cogan syndrome; Angina pectoris; Aortitis.
Received: April 12, 2010
Revision Received: May 17, 2010
Accepted: May 23, 2010
Correspondence: Wook Hyun Cho, MD, Division of Cardiology, Depart-
ment of Internal Medicine, Sahmyook Medical Center, Seoul Adventist 
Hospital, 29-1 Hwigyung 2-dong, Dongdaemun-gu, Seoul 130-092, Korea
Tel: 82-2-2210-3502, Fax: 82-2-2212-2673
E-mail: mulgang@gmail.com
cc This is an Open Access article distributed under the terms of the Cre-
ative Commons Attribution Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/3.0) which permits unrestricted non-commer-
cial use, distribution, and reproduction in any medium, provided the origi-
nal work is properly cited.
 Introduction
Cogan’s syndrome is a rare systemic disease that is charac-
terized by progressive inflammation in the ocular and audio-
vestibular organs.
1) It can be associated with other systemic in-
flammatory manifestations such as fever, arthralgia, anemia, 
skin rash, neurological disease, gastrointestinal tract disease, 
vasculitis, and aortitis.
2)3) 
We report a 42-year-old woman with Cogan’s syndrome who 
presented with angina. 
Case
A 42-year-old female was admitted with effort angina for 2 
months. She had no major risk factors for cardiovascular dis-
ease such as diabetes mellitus, hypertension, dyslipidemia, sm-
oking, and family history of cardiovascular disease. Five years 
previously she had suffered tinnitus, vertigo, and hearing dis-
turbance that progressed to sensorineural hearing loss despite 
medical therapy. Four years previously she had been treated for 
recurrent ocular problems such as red eyes, photophobia, oc-
ular pain, and increased tearing for 2 years. 
At the time of admission, brachial blood pressures were 
90/50 mmHg in the left arm and 96/57 mmHg in the right arm. 
The pulse rate was 64 beats per minute and respiration rate was 
16 breaths per minute. Her body temperature was 36.5°C. A 
diastolic murmur at the cardiac base and systolic bruits over 
bilateral subclavicular area were heard. No abnormal physi-
cal findings were observed in the abdomen, joints, and skin. 
The neurological examination was entirely normal, except for 
neurosensory deafness. Ophthalmologic examination showed 
that her visual acuity, corneas, anterior chambers, pupils and 
iris were normal at that time.
The laboratory test results were as follows: white blood 
cell count 8,100/mm
3, hemoglobin 10.7 g/dL, platelet count 
439,000/mm
3, erythrocyte sedimentation rate 73 mm/hr, C-re-
active protein 2.6 mg/dL. She tested negative for autoimmune 
tests (antinuclear antibody, antineutrophil cytoplasmic antibody, 
rheumatoid factors, antiphospholipid antibodies, complements) 
and negative for syphilis serology tests (VDRL, FTA-Abs).
The resting electrocardiogram showed normal sinus rhythm 
with non-specific ST-T changes (Fig. 1A). However, during the 
treadmill test ischemic ST segment depression appeared at 
stage 2 of the Bruce protocol (Fig. 1B). Transthoracic echocar-
diogram revealed normal ejection fraction (68%), normal aor-
tic root size (2.8 cm) and normal chamber size (diastolic left ven-
tricular dimension: 5.5 cm, systolic left ventricular dimension: 
3.4 cm). The transesophageal echocardiogram revealed re-
tracted tips of aortic cusps (Fig. 2A), moderate aortic regurgi-
tation (Fig. 2B), and thickened wall of the descending thoracic 
aorta (Fig. 2C). 
The coronary angiography showed stenoses at both the left 
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demonstrated stenosis at both subclavian arteries (Fig. 3C), but 
the renal arteries were intact. Intravascular ultrasound (iLab 
40 MHz; Boston Scientific, Natick, MA, USA) showed nega-
tive remodeling and stenoses with tissue proliferation at both 
coronary artery ostia (Fig. 4). The patient underwent percu-
taneous coronary intervention at the left main ostium with a 
drug eluting stent (Endeavor Resolute, Medtronic Vascular, 
Santa Rosa, CA, USA) (4.0×15 mm) (Fig. 5). Her effort angi-
na subsided. To control the active stage of the vasculitis, pred-
nisolone 50 mg per day was given. After 4 weeks, her erythro-
cyte sedimentation rate and C-reactive protein normalized. 
However, permanent hearing loss persisted.
 
Discussion
Cogan’s syndrome is an uncommon systemic inflammato-
ry disease characterized by involvement of the eyes and the in-
ner ear.
2) It was defined by David Cogan, an ophthalmolo-
gist, in 1945 as a nonsyphilitic keratitis and an audiovestibular 
function disorder resembling Meniere’s disease occurring wi-
thin 2 years of each other.
1) It is classified into two types, typi-
cal and atypical, according to the type of ocular manifesta-
tions. In the presence of interstitial keratitis, it is classified as ty-
pical type. Other ocular problems such as conjunctivitis, uvei-
tis, scleritis, and choroiditis lead to classification as atypical 
type.
3) 
The peak incidence occurs in the third decade of life. There 
are no gender or racial differences in disease prevalence and its 
precise etiology is unknown. However, an immunologic role 
has been suggested by some authors because immunosuppres-
sive agents are effective.
4)5) 
In addition to the ocular and audiovestibular disorders, vari-
ous systemic manifestations including fever, weight loss, arth-
ritis, arthralgia, lymphadenopathy, skin rash, neurological dis-
order, gastrointestinal disease, vasculitis, and aortic insuffici-
ency are reported. The most characteristic cardiovascular ma-
nifestation of Cogan’s syndrome is aortitis. Aortitis has been 
described in approximately 10 percent of patients and can lead 
to proximal aorta dilation, aortic valvular regurgitation, cor-
onary ostial stenosis, and thoracoabdominal aneurysms.
6) Our 
case had manifestations compatible with vasculitis or aortitis 
such as bilateral subclavian artery stenosis, bilateral coronary 
Fig. 1. Exercise electrocardiogram. A: baseline electrocardiogram shows normal sinus rhythm with nonspecific ST-T changes. B: electro-
cardiogram during exercise at Bruce protocol stage 2 reveals significant ST segment depressions at lead II, III, aVF, V4, V5, V6.
A   B
Fig. 2. Transesophageal echocardiogram shows retracted tips of 
aortic cusps in systolic phase (A), moderate aortic regurgitation in 
diastolic phase (B), and increased wall thickening at the descend-
ing thoracic aorta (C). Arrow indicates thickened intima.
A  
C
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ostial stenosis, arotic valve regurgitation and thickened tho-
racic aortic wall. There is no difference in incidence of aortitis 
between typical and atypical Cogan’s syndrome.
3) In addition 
to aortitis, she had aortic regurgitation due to retracted cusps 
of aortic valve probably caused by valvulitis. 
Differential diagnoses to consider are Takayasu’s arteritis, 
polyarteritis nodosa, Wegener’s granulomatosis, Giant cell 
arteritis, and rheumatic arthritis.
5) It is particularly difficult 
to distinguish between Takayasu’s arteritis and the vasculitis 
of Cogan’s syndrome in the sense that they both involve large 
vessel vasculitis. However, unlike Cogan’s syndrome, Takaya-
su’s arteritis does not routinely involve the eyes and ears.
7-9)
The treatment of Cogan’s syndrome depends on the exten-
sion of the disease. If a mild eye involvement is the only mani-
festation, topical glucocorticoid is the treatment of choice. But 
in cases of systemic vasculitis, hearing loss, or severe infection 
of an eye, systemic immunosuppressive therapy is required. 
Glucocorticoid (prednisolone 1 mg/kg) is the first choice ag-
ent.
5) If the response is incomplete, the addition of another 
immunosuppressive agent should be considered. Methotrex-
ate or cyclophosphamide have been found to be effective in 
some reports.
10)11) In patients with severe ischemic symptoms 
or heart failure, surgical bypass grafting or aortic valve replace-
ment should be considered.
12) Our case underwent percuta-
neous coronary intervention with a stent to resolve angina ca-
used by stenosis of the left main ostium. 
The prognosis for maintenance of vision and resolution of 
Fig. 3. Angiography shows ostial left main stenosis (A), ostial right coronary stenosis (B), and bilateral subclavian stenosis (C). A: right an-
terior oblique view. B: left anterior oblique view. C: anteroposterior view.
A   B C  
Fig. 4. Intravascular ultrasound shows increased intimal thickening at distal left main coronary (A) and negative remodeling with stenosis at 
ostial left main coronary artery (B).
A   B
Fig. 5. Angiography after successful stenting shows widened left 
main ostium.Jong Sang Kim, et al.   683
inflammatory eye lesions is generally good. However, deafness 
generally remains permanent, even after administration of cor-
ticosteroid and immunosuppressive agents.
6) Our case receiv-
ed glucocorticoid therapy because she had increased eryth-
rocyte sedimentation rate and C-reactive protein. After 1 
month of therapy, the inflammatory indices had normalized 
but the deafness had not improved. Cochlear implants are ef-
fective in patients with deafness.
6) She is therefore planning to 
undergo such a procedure. Patients without systemic disease 
generally have a good prognosis and an average life expec-
tancy.
1) However, other patients may require prolonged treat-
ment because of recurrent hearing loss or other morbidities. 
Patients who develop serious vasculitis, such as aortitis, have 
an increased risk of death due to complications.
1) Therefore, 
early assessment and treatment for systemic inflammation 
are needed to prevent life threatening complications.
2) 
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